Advertisement

Topics

Phase 2b Results of Viamet’s Oral VT-1161 for the Treatment of Recurrent Vulvovaginal ...

03:06 EDT 11 Aug 2017 | BioMedReports - Blog
- Presentation detailed the Company’s REVIVE study data demonstrating unprecedented results in the treatment of RVVC -

Read more...

Original Article: Phase 2b Results of Viamet’s Oral VT-1161 for the Treatment of Recurrent Vulvovaginal ...

NEXT ARTICLE

More From BioPortfolio on "Phase 2b Results of Viamet’s Oral VT-1161 for the Treatment of Recurrent Vulvovaginal ..."

Quick Search
Advertisement